New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - ondansetron hydrochloride dihydrate 2.5 mg/ml equivalent to 2 mg/ml ondansetron base - solution for injection - 2 mg/ml - active: ondansetron hydrochloride dihydrate 2.5 mg/ml equivalent to 2 mg/ml ondansetron base excipient: citric acid monohydrate sodium chloride sodium citrate dihydrate water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - ondansetron hydrochloride dihydrate 2.5 mg/ml equivalent to 2 mg/ml ondansetron. - solution for injection - 2 mg/ml - active: ondansetron hydrochloride dihydrate 2.5 mg/ml equivalent to 2 mg/ml ondansetron. excipient: citric acid monohydrate sodium chloride sodium citrate dihydrate water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - ondansetron hydrochloride dihydrate 2.5 mg/ml equivalent to ondansetron 2 mg/ml;   - solution for injection - 2 mg/ml - active: ondansetron hydrochloride dihydrate 2.5 mg/ml equivalent to ondansetron 2 mg/ml   excipient: citric acid monohydrate sodium chloride sodium citrate dihydrate water for injection - ondansetron injection is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. ondansetron injection is also indicated for the prevention and treatment of post-operative nausea and vomiting.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - ondansetron hydrochloride dihydrate, quantity: 2.5 mg/ml (equivalent: ondansetron, qty 2 mg/ml) - injection, solution - excipient ingredients: sodium chloride; citric acid monohydrate; sodium citrate dihydrate; water for injections - ondansetron injection is indicated for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy. ondansetron injection is also indicated for the prevention and treatment of post-operative nausea and vomiting.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - ondansetron hydrochloride dihydrate, quantity: 2.5 mg/ml (equivalent: ondansetron, qty 2 mg/ml) - injection, solution - excipient ingredients: water for injections; sodium chloride; citric acid monohydrate; sodium citrate dihydrate - ondansetron injection is indicated for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy. ondansetron injection is also indicated for the prevention and treatment of post-operative nausea and vomiting.

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - ondansetron hydrochloride dihydrate 2.5 mg/ml equivalent to to 2 mg/ml ondansetron base - solution for injection - 2 mg/ml - active: ondansetron hydrochloride dihydrate 2.5 mg/ml equivalent to to 2 mg/ml ondansetron base excipient: citric acid monohydrate sodium chloride sodium citrate dihydrate water for injection - zofran tablets, zofran solution for injection and zofran zydis wafers are indicated for: · management of nausea and vomiting induced by cytotoxic chemotherapy in children, adolescents and adults. · management of nausea and vomiting induced by radiotherapy in adults. zofran solution for injection is also indicated for: · prevention of post-operative nausea and vomiting in children, adolescents and adults. studies have not be conducted on the use of zofran tablets or zofran zydis wafers in the prevention of post-operative nausea and vomiting in the paediatric population.

New Zealand - English - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - ondansetron hydrochloride dihydrate 2.49 mg/ml equivalent to 2 mg ondansetron - solution for injection - 2 mg/ml - active: ondansetron hydrochloride dihydrate 2.49 mg/ml equivalent to 2 mg ondansetron excipient: citric acid monohydrate sodium chloride sodium citrate dihydrate water for injection - the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - ondansetron hydrochloride dihydrate, quantity: 5 mg (equivalent: ondansetron, qty 4 mg) - injection, solution - excipient ingredients: water for injections; citric acid monohydrate; sodium citrate dihydrate; sodium chloride - ondansetron injection is indicated for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy. ondansetron injection is also indicated for the prevention and treatment of post-operative nausea and vomiting.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - ondansetron hydrochloride dihydrate, quantity: 9.98 mg (equivalent: ondansetron, qty 8 mg) - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium hydroxide; sodium chloride; sodium citrate dihydrate; citric acid monohydrate - ondansetron injection is indicated ? for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy. ? for the prevention and treatment of post-operative nausea and vomiting.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - ondansetron hydrochloride dihydrate, quantity: 4.99 mg (equivalent: ondansetron, qty 4 mg) - injection, solution - excipient ingredients: water for injections; sodium hydroxide; citric acid monohydrate; sodium citrate dihydrate; hydrochloric acid; sodium chloride - ondansetron injection is indicated ? for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy. ? for the prevention and treatment of post-operative nausea and vomiting.